Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 22, 2023

Anchen Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?

ANCHEN PHARMS has twenty-seven approved drugs.

There are two tentative approvals on ANCHEN PHARMS drugs.

Summary for Anchen Pharms

US Patents:	0
Tradenames:	23
Ingredients:	23
NDAs:	27

Drugs and US Patents for Anchen Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Anchen Pharms	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	091520-001	Jun 9, 2011	AB2	RX	No	No		See Plans and Pricing				See Plans and Pricing
Anchen Pharms	CLONIDINE HYDROCHLORIDE	clonidine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	202983-002	Apr 2, 2014		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Anchen Pharms	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	202010-001	Jan 4, 2013		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Anchen Pharms	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	078087-002	Mar 16, 2012		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Anchen Pharms	TRAMADOL HYDROCHLORIDE	tramadol hydrochloride	TABLET, EXTENDED RELEASE;ORAL	200491-002	Jun 27, 2012		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Anchen Pharms	DARIFENACIN HYDROBROMIDE	darifenacin hydrobromide	TABLET, EXTENDED RELEASE;ORAL	091190-002	Mar 13, 2015		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Anchen Pharms

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Baxter

Merck

Colorcon

Johnson and Johnson

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.